Amicus Therapeutics, Inc.
FOLD
$9.13
$0.232.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.42M | -21.69M | 14.74M | -6.73M | -15.70M |
| Total Depreciation and Amortization | 1.85M | 1.84M | 2.04M | 2.17M | 2.18M |
| Total Amortization of Deferred Charges | 630.00K | 606.00K | 597.00K | 574.00K | 560.00K |
| Total Other Non-Cash Items | 24.46M | 20.99M | 22.45M | 24.99M | 24.55M |
| Change in Net Operating Assets | -29.05M | 6.01M | -43.74M | -43.98M | 11.09M |
| Cash from Operations | -26.53M | 7.76M | -3.92M | -22.97M | 22.69M |
| Capital Expenditure | -2.40M | -212.00K | -288.00K | -356.00K | -1.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.38M | -32.65M | -20.10M | 34.63M | -20.88M |
| Cash from Investing | -5.78M | -32.86M | -20.39M | 34.27M | -21.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.00K | -15.00K | -43.00K | 24.00K | -36.00K |
| Issuance of Common Stock | 40.00K | 105.00K | 1.97M | 20.96M | 863.00K |
| Repurchase of Common Stock | -432.00K | -11.79M | -828.00K | -2.79M | -1.68M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -400.00K | -11.70M | 1.10M | 18.19M | -857.00K |
| Foreign Exchange rate Adjustments | 9.99M | 4.82M | 3.11M | -5.03M | -294.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.72M | -31.98M | -20.10M | 24.46M | -437.00K |